Ngā hua rapu - Caesar Atuire

  • E whakaatu ana i te 1 - 6 hua o te 6
Whakamahine hua
  1. 1
    What’s yours is ours: waiving intellectual property protections for COVID-19 vaccines

    What’s yours is ours: waiving intellectual property protections for COVID-19 vaccines mā Nancy S. Jecker, Caesar Atuire

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    War, Bioethics, and Public Health

    War, Bioethics, and Public Health mā Nancy S. Jecker, Caesar Atuire, Vardit Ravitsky, Kevin Behrens, Mohammed Ghaly

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Research ethics and artificial intelligence for global health: perspectives from the global forum on bioethics in research

    Research ethics and artificial intelligence for global health: perspectives from the global forum on bioethics in research mā James Shaw, Joseph Ali, Caesar Atuire, Phaik Yeong Cheah, Armando Guio Español, Judy Wawira Gichoya, Adrienne Hunt, Daudi Jjingo, Katherine Littler, Daniela Paolotti, Effy Vayena

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group

    Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group mā Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, Ruth Faden, Prakash Ghimire, Dirceu Bartolomeu Greco, Calvin Wai-Loon Ho, Suerie Moon, Ehsan Shamsi Gooshki, Aissatou Touré, Beatriz Thomé, Maxwell J. Smith, Ross Upshur

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations

    WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations mā Jerome Amir Singh, Sonali Kochhar, Jonathan Wolff, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, Ruth Faden, Prakash Ghimire, Dirceu Bartolomeu Greco, Calvin Wai-Loon Ho, Suerie Moon, Ehsan Shamsi Gooshki, Aissatou Touré, Beatriz Thomé, Maxwell J. Smith, Ross Upshur

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines

    Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines mā Jonathan Wolff, Caesar Atuire, Anant Bhan, Ezekiel Emanuel, Ruth Faden, Prakash Ghimire, Dirceu Bartolomeu Greco, Calvin Wai-Loon Ho, Sonali Kochhar, Surie Moon, G. Owen Schaefer, Ehsan Shamsi Gooshki, Jerome Amir Singh, Maxwell J. Smith, Beatriz Thomé, Aissatou Touré, Ross Upshar

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: